- Previous Close
18.99 - Open
19.92 - Bid 18.48 x --
- Ask 18.50 x --
- Day's Range
18.40 - 19.20 - 52 Week Range
8.40 - 20.36 - Volume
5,477,090 - Avg. Volume
10,073,911 - Market Cap (intraday)
17.143B - Beta (5Y Monthly) 0.39
- PE Ratio (TTM)
102.61 - EPS (TTM)
0.18 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 20, 2022
- 1y Target Est
15.00
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.
www.ask-pharm.com979
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 002755.SZ
View MorePerformance Overview: 002755.SZ
Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002755.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002755.SZ
View MoreValuation Measures
Market Cap
17.14B
Enterprise Value
15.16B
Trailing P/E
102.61
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.91
Price/Book (mrq)
5.74
Enterprise Value/Revenue
8.88
Enterprise Value/EBITDA
107.54
Financial Highlights
Profitability and Income Statement
Profit Margin
9.55%
Return on Assets (ttm)
0.59%
Return on Equity (ttm)
4.09%
Revenue (ttm)
1.71B
Net Income Avi to Common (ttm)
163.14M
Diluted EPS (ttm)
0.18
Balance Sheet and Cash Flow
Total Cash (mrq)
2.08B
Total Debt/Equity (mrq)
3.28%
Levered Free Cash Flow (ttm)
111.59M